|
시장보고서
상품코드
1812427
세계의 DNA 제조 시장 : DNA 유형별, 용도별, 기술별, 등급별, 생산 스케일별, 최종 사용자별, 지역별DNA Manufacturing Market, By Type of DNA, By Application, By Technology, By Grade, By Production Scale, By End User, By Geography |
||||||
세계의 DNA 제조 시장은 2025년 64억 4,000만 달러로 추정되고, 2023년까지 195억 6,000만 달러에 이를 전망으로, 2025년부터 2032년까지 연평균 성장률(CAGR) 17.2%로 성장이 예측되고 있습니다.
| 보고 범위 | 보고서 세부정보 | ||
|---|---|---|---|
| 기준연도 | 2024년 | 2025년 시장 규모 | 64억 4,000만 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2020-2024년 |
| 예측기간 : 2025-2032년 CAGR : | 17.20% | 2032년 가치 예측 | 195억 6,000만 달러 |
세계의 DNA 제조 시장은 바이오테크놀러지 산업에서 빠르게 발전하고 있는 분야로, 제약, 연구, 진단, 치료의 각 영역에서 다양한 용도를 위한 데옥시리보 핵산(DNA)의 생산, 합성, 상업적 제조를 포함하고 있습니다. 이 시장은 유전 공학, 합성 생물학 및 맞춤형 의료의 전례없는 진보로 현대 바이오 경제의 중요한 구성 요소로 부상했습니다. DNA 제조에는 고품질 DNA 구조물, 플라스미드, 올리고뉴클레오티드, 합성 유전자를 만드는 화학 합성, 효소 생산, 바이오 제조 기술 등의 고급 공정이 포함됩니다.
이 시장은 유전자 치료 및 백신을 개발하는 제약 회사에서부터 기초적인 유전자 연구를 수행하는 학술 연구 기관에 이르기까지 다양한 최종 사용자에게 서비스를 제공합니다. 주요 제조 공정은 고체상 합성, PCR 증폭, 발효 기반 생산 시스템 등으로 확장 가능하고 비용 효율적인 DNA 생산이 가능합니다. 이 업계에서는 자동화, 품질 관리 시스템 및 정제 방법에 있어서 상당한 기술 혁신을 볼 수 있어 생산 효율과 제품 품질이 모두 향상되었습니다. 세계적인 초점이 정밀의료, CRISPR-Cas9와 같은 유전자 편집 기술, 차세대 치료제로 이동하는 가운데, DNA 제조 시장은 종양학, 희귀질환, 감염증을 포함한 여러 치료 분야에 걸쳐 그 발자취를 계속 확대해 현대 생명공학의 진보에 필수적인 기둥으로서의 지위를 확립하고 있습니다.
시장 역학
세계의 DNA 제조 시장은 생명공학의 전망을 근본적으로 바꾸고 전례 없는 성장 기회를 창출하는 몇 가지 강력한 촉진요인에 의해 지원되고 있습니다. 그 첫 번째 요인은 유전자 치료 개발의 급격한 성장이며, 수많은 임상시험이 규제 당국의 파이프라인을 통과하고 USFDA 및 EMA 등의 기관으로부터 승인을 받아 고품질의 치료용 DNA 제품에 대한 큰 수요가 탄생하고 있습니다. COVID-19 팬데믹은 신속한 백신 개발과 생산 능력, 특히 생산에 첨단 DNA 템플릿과 플라스미드를 필요로 하는 mRNA 백신의 중요성을 부각시켜 시장 성장을 현저하게 가속화했습니다. 합성 생물학 및 유전 공학 연구에 대한 민간 및 공공 부문 투자 증가는 맞춤형 DNA 합성 서비스와 표준화된 DNA 구성요소에 대한 수요를 촉진하고 있습니다. 그러나 시장은 광범위한 문서화, 품질 관리 조치, 적절한 제조 기준(GMP) 준수를 요구하는 엄격한 규제 프레임워크를 포함한 현저한 억제요인에 직면하고 있으며, 이는 생산 비용과 시장 출시까지의 시간을 크게 증가시킵니다. 최첨단 제조 시설을 설립하는 데 필요한 고액의 설비 투자와 전문적인 숙련 인력과 고급 장비의 필요성이 신규 시장 진입의 장벽이 되고 있습니다. DNA 안정성 유지, 순도 수준 확보, 실험실 규모에서 상업 규모로의 생산 공정 확장에 관한 기술적 과제는 여전히 경영상의 제약이 되고 있습니다. 그럼에도 불구하고, DNA 데이터 보존, 농업 생명공학, 환경 복구 등 신흥 분야에서의 DNA 응용의 확대가 이 시장에 큰 비즈니스 기회를 가져오고 있습니다. 개인화된 의료 접근법의 채택 확대는 환자 특이적 DNA 구조와 맞춤형 제조 서비스에 대한 수요를 야기하고 있습니다. 자동화, 인공지능 주도의 품질관리, 신규 합성법 등의 기술적 진보로 비용 절감과 효율 향상을 위한 새로운 길이 열리고 있는 한편, 세계적인 유전성 질환의 유병률 증가로 DNA 기반 치료 솔루션의 대응가능 시장은 계속 확대되고 있습니다.
본 조사의 주요 특징
- 본 보고서에서는 세계의 DNA 제조 시장을 상세하게 분석하여 2024년을 기준연도로 한 예측기간(2025-2032년) 시장 규모(10억 달러)와 연간 평균 성장률(CAGR%)을 제공합니다.
- 또한 다양한 부문에서 잠재적인 수익 기회를 밝히고 이 시장의 매력적인 투자 제안 행렬을 설명합니다.
- 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품의 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채용하는 경쟁 전략 등에 관한 중요한 고찰도 제공합니다.
- 엔터프라이즈 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등의 매개변수를 기반으로 세계 DNA 제조 시장의 주요 기업을 프로파일링합니다.
- 이 보고서의 통찰을 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 타이핑, 시장 확대, 마케팅 전술에 대한 정보를 바탕으로 의사 결정을 내릴 수 있습니다.
- 세계의 DNA 제조 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 참가자, 재무 분석가 등 이 업계의 다양한 이해관계자를 지원합니다.
- 이해관계자는 세계 DNA 제조 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사 결정을 용이하게 할 수 있습니다.
목차
제1장 조사의 목적과 전제조건
- 조사 목적
- 전제조건
- 약어
제2장 시장 전망
- 보고서 설명
- 시장 정의와 범위
- 주요 요약
제3장 시장 역학, 규제, 동향 분석
- 시장 역학
- 성장 촉진요인
- 억제요인
- 기회
- 영향 분석
- 주요 발전
- 규제 시나리오
- 제품 출시/승인
- PEST 분석
- Porter's Five Forces 분석
- 합병과 인수 시나리오
- 업계 동향
제4장 세계의 DNA 제조 시장, DNA 유형별, 2020-2032년
- 합성 DNA
- 플라스미드 DNA
- 유전자 DNA
제5장 세계의 DNA 제조 시장, 용도별, 2020-2032년
- 종양
- 유전자 치료
- 백신 개발
- 면역요법
- 재생 의료
- 신경퇴행성 질환
- 심혈관 질환
- 감염증
- 기타(희소 유전성 질환)
제6장 세계의 DNA 제조 시장, 기술별, 2020-2032년
- PCR(중합효소 연쇄반응)
- CRISPR/Cas9
- 차세대 시퀀싱(NGS)
- 유전자 합성
- 기타(유전자 편집 및 변형)
제7장 세계의 DNA 제조 시장, 등급별, 2020-2032년
- GMP 등급(적정 제조 기준)
- R&D 등급(연구개발)
제8장 세계의 DNA 제조 시장, 생산 스케일별, 2020-2032년
- 상업 스케일 생산
- 커스텀 스케일 생산
제9장 세계의 DNA 제조 시장, 최종 사용자별, 2020-2032년
- 제약회사
- 바이오테크놀러지 기업
- 계약 연구 기관
- 기타(학술 및 연구 기관 등)
제10장 세계의 DNA 제조 시장, 지역별, 2020-2032년
- 북미
- 미국
- 캐나다
- 라틴아메리카
- 브라질
- 아르헨티나
- 멕시코
- 기타 라틴아메리카
- 유럽
- 독일
- 영국
- 스페인
- 프랑스
- 이탈리아
- 러시아
- 기타 유럽
- 아시아태평양
- 중국
- 인도
- 일본
- 호주
- 한국
- ASEAN
- 기타 아시아태평양
- 중동
- GCC 국가
- 이스라엘
- 기타 중동
- 아프리카
- 남아프리카
- 북아프리카
- 중앙 아프리카
제11장 경쟁 구도
- Lonza Group
- WuXi AppTec
- GenScript Biotech
- Thermo Fisher Scientific
- Sigma-Aldrich(Merck Group)
- Integrated DNA Technologies
- Eurofins Genomics
- OriGene Technologies
- Bluebird Bio
- Sangamo Therapeutics
- Cellectis
- Caribou Biosciences
- Editas Medicine
- Intellia Therapeutics
제12장 분석가 추천
- 기회
- 애널리스트의 견해
- Coherent Opportunity Map
제13장 참고문헌과 조사방법
- 참고문헌
- 조사 방법
- 출판사에 대해
DNA Manufacturing Market is estimated to be valued at USD 6.44 Bn in 2025 and is expected to reach USD 19.56 Bn by 2032, growing at a compound annual growth rate (CAGR) of 17.2% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 6.44 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 17.20% | 2032 Value Projection: | USD 19.56 Bn |
The global DNA manufacturing market represents a rapidly evolving sector within the biotechnology industry, encompassing the production, synthesis, and commercial manufacturing of deoxyribonucleic acid (DNA) for various applications across pharmaceutical, research, diagnostic, and therapeutic domains. This market has emerged as a critical component of the modern bioeconomy, driven by unprecedented advances in genetic engineering, synthetic biology, and personalized medicine. DNA manufacturing involves sophisticated processes including chemical synthesis, enzymatic production, and bio-manufacturing techniques to create high-quality DNA constructs, plasmids, oligonucleotides, and synthetic genes.
The market serves diverse end users ranging from pharmaceutical companies developing gene therapies and vaccines to academic research institutions conducting fundamental genetic research. Key manufacturing processes include solid-phase synthesis, PCR amplification, and fermentation-based production systems that enable scalable and cost-effective DNA production. The industry has witnessed significant technological breakthroughs in automation, quality control systems, and purification methodologies, enhancing both production efficiency and product quality. As the global focus shifts toward precision medicine, gene editing technologies like CRISPR-Cas9, and next-generation therapeutics, the DNA manufacturing market continues to expand its footprint across multiple therapeutic areas including oncology, rare diseases, and infectious diseases, establishing itself as an indispensable pillar of modern biotechnological advancement.
Market Dynamics
The global DNA manufacturing market is propelled by several robust drivers that are fundamentally reshaping the biotechnology landscape and creating unprecedented growth opportunities. The primary driver stems from the exponential growth in gene therapy development, with numerous clinical trials advancing through regulatory pipelines and receiving approvals from agencies like the USFDA and EMA, creating substantial demand for high-quality therapeutic DNA products. The COVID-19 pandemic significantly accelerated market growth by highlighting the critical importance of rapid vaccine development and manufacturing capabilities, particularly for mRNA vaccines that require sophisticated DNA templates and plasmids for production. Rising investments in synthetic biology and genetic engineering research by both private and public sectors are driving demand for custom DNA synthesis services and standardized DNA components. However, the market faces notable restraints including stringent regulatory frameworks that require extensive documentation, quality control measures, and compliance with Good Manufacturing Practice (GMP) standards, which significantly increase production costs and time-to-market. The high capital investment required for establishing state-of-the-art manufacturing facilities, coupled with the need for specialized skilled personnel and advanced equipment, creates barriers for new market entrants. Technical challenges related to maintaining DNA stability, ensuring purity levels, and scaling production processes from laboratory to commercial scale continue to pose operational constraints. Nevertheless, the market presents substantial opportunities driven by the expanding applications of DNA in emerging fields such as DNA data storage, agricultural biotechnology, and environmental remediation. The growing adoption of personalized medicine approaches is creating demand for patient-specific DNA constructs and custom manufacturing services. Technological advancements in automation, artificial intelligence-driven quality control, and novel synthesis methods are opening new avenues for cost reduction and efficiency improvements, while the increasing prevalence of genetic disorders globally continues to expand the addressable market for DNA-based therapeutic solutions.
Key Features of the Study
- This report provides in-depth analysis of the global DNA manufacturing market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global DNA manufacturing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Lonza Group, WuXi AppTec, GenScript Biotech, Thermo Fisher Scientific, Sigma-Aldrich (Merck Group), Integrated DNA Technologies, Eurofins Genomics, OriGene Technologies, Bluebird Bio, Sangamo Therapeutics, Cellectis, Caribou Biosciences, Editas Medicine, and Intellia Therapeutics.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global DNA manufacturing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global DNA manufacturing market.
Market Segmentation
- Type of DNA Insights (Revenue, USD Bn, 2020 - 2032)
- Synthetic DNA
- Oligonucleotide synthesis
- Custom DNA synthesis
- Plasmid DNA
- Gene DNA
- Application Insights (Revenue, USD Bn, 2020 - 2032)
- Oncology
- Gene Therapy
- Vaccine Development
- Immunotherapy
- Regenerative Medicine
- Neurodegenerative Diseases
- Cardiovascular Diseases
- Infectious Diseases
- Others (Rare Genetic Disorders)
- Technology Insights (Revenue, USD Bn, 2020 - 2032)
- PCR (Polymerase Chain Reaction)
- CRISPR/Cas9
- Next-Generation Sequencing (NGS)
- Gene Synthesis
- Others (Gene Editing and Modification)
- Grade Insights (Revenue, USD Bn, 2020 - 2032)
- GMP Grade (Good Manufacturing Practice)
- R and D Grade (Research and Development)
- Production Scale Insights (Revenue, USD Bn, 2020 - 2032)
- Commercial Scale Production
- Custom Scale Production
- End User Insights (Revenue, USD Bn, 2020 - 2032)
- Pharmaceutical Companies
- Biotechnology Companies
- Contract Research Organizations
- Others (Academic and Research Institutions, etc.)
- Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Lonza Group
- WuXi AppTec
- GenScript Biotech
- Thermo Fisher Scientific
- Sigma-Aldrich (Merck Group)
- Integrated DNA Technologies
- Eurofins Genomics
- OriGene Technologies
- Bluebird Bio
- Sangamo Therapeutics
- Cellectis
- Caribou Biosciences
- Editas Medicine
- Intellia Therapeutics
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global DNA Manufacturing Market, By Type of DNA
- Global DNA Manufacturing Market, By Application
- Global DNA Manufacturing Market, By Technology
- Global DNA Manufacturing Market, By Grade
- Global DNA Manufacturing Market, By Production Scale
- Global DNA Manufacturing Market, By End User
- Global DNA Manufacturing Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global DNA Manufacturing Market, By Type of DNA, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Synthetic DNA
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Oligonucleotide synthesis
- Custom DNA synthesis
- Plasmid DNA
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Gene DNA
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
5. Global DNA Manufacturing Market, By Application, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Gene Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Vaccine Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Immunotherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Regenerative Medicine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Neurodegenerative Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Cardiovascular Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others (Rare Genetic Disorders)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global DNA Manufacturing Market, By Technology, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- PCR (Polymerase Chain Reaction)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- CRISPR/Cas9
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Next-Generation Sequencing (NGS)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Gene Synthesis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others (Gene Editing and Modification)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global DNA Manufacturing Market, By Grade, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- GMP Grade (Good Manufacturing Practice)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- R and D Grade (Research and Development)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global DNA Manufacturing Market, By Production Scale, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Commercial Scale Production
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Custom Scale Production
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
9. Global DNA Manufacturing Market, By End User, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Pharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Contract Research Organizations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others (Academic and Research Institutions, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
10. Global DNA Manufacturing Market, By Region, 2020 - 2032, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2020 - 2032, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Type of DNA, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Grade, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Production Scale, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Type of DNA, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Grade, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Production Scale, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Type of DNA, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Grade, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Production Scale, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Type of DNA, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Grade, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Production Scale, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Type of DNA, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Grade, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Production Scale, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Type of DNA, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Grade, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Production Scale, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
11. Competitive Landscape
- Lonza Group
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- WuXi AppTec
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GenScript Biotech
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Thermo Fisher Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sigma-Aldrich (Merck Group)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Integrated DNA Technologies
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Eurofins Genomics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- OriGene Technologies
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bluebird Bio
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sangamo Therapeutics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cellectis
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Caribou Biosciences
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Editas Medicine
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Intellia Therapeutics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
12. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
13. References and Research Methodology
- References
- Research Methodology
- About us
